InvestorsHub Logo
Followers 26
Posts 4067
Boards Moderated 0
Alias Born 12/26/2018

Re: JTORENCE post# 358730

Monday, 05/10/2021 4:02:16 PM

Monday, May 10, 2021 4:02:16 PM

Post# of 403217
How would they review a drug that doesn't have any COVID-19 results in the clinic?

Also if you follow the link on the reddit page:

https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/treatments-covid-19/covid-19-treatments-research-development#covid-19-treatments-that-have-received-ema-advice-section

The table of contents is the follwoing:

COVID-19 treatments that have received EMA advice
Ongoing clinical trials in the EU

B-COVID likely has not received EMA advice and obviously does not have ongoing clinical trials in the EU.

Go IPIX!

Brilacidin! The hottest COVID-19 drug of 2023.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News